Nocturnal Inc.
About Nocturnal Inc.
Nocturnal’s mission is to help early stage medical device companies accelerate the path to commercialization for class II and class III, implantables, wearables, and lifesaving devices. The company provides design, engineering, and data strategy aligned from day one with clinical objectives, regulatory requirements, and manufacturing constraints. It focuses on reducing risks such as runaway costs, architectures that collapse toward manufacturing, and data that cannot support AI, clinical, or regulatory needs.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $1.85M via private placement with no investors disclosed.
- Headquartered in Cambridge, MA and focused on Other Health Care.
- Specializes in accelerating commercialization for class II and III medical devices including implantables and wearables.
- Emphasizes risk reduction in design, engineering, and regulatory pathways for device startups.
Ask StreetZero about Nocturnal Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account